Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
AGORACOM NEWS FLASH

Dear Agoracom Family,

I want to thank all of you for your patience with us over the past 48 hours and apologize for what was admittedly a botched launch of our new site.

As you can see, we have reverted back to the previous version of the site while we address multiple forum functionality flaws that inexplicably made their way into the launch.

To this end:

1.We have identified 8 fundamental but easily fixable flaws that will be corrected in the coming week, so that you can continue to use the forums exactly as you've been accustomed to.

2.Additionally we will also be implementing a couple of design improvements to "tighten up" the look and feel of the forums.

Sincerely,

George et al

Message: Filing

16-Aug-2016

Entry into a Material Definitive Agreement, Financial Statements and Exhi


Item 1.01 Entry Into a Material Definitive Agreement.

On August 10, 2016, the joint venture of Patriot Scientific Corporation (the "Company") and Technology Properties Limited LLC ("TPL"), known as Phoenix Digital Solutions, LLC, a Delaware limited liability company ("PDS"), entered into an Agreement (the "Agreement") with MMP Licensing LLC, a California limited liability company ("MMP Licensing LLC"), and Alliacense Limited LLC, a Delaware limited liability company ("Alliacense").

Pursuant to the Agreement, MMP Licensing LLC will provide commercialization services to PDS for commercialization of the Moore Microprocessor Patent portfolio (the "MMP Portfolio") with respect to certain companies (the "Project"). PDS also granted a license to MMP Licensing LLC for the commercialization of the MMP Portfolio.

Alliacense agreed to cooperate with reasonable discovery requests and provide support to litigation counsel through the provision of properly produced and protected materials in connection with patent infringement litigation currently pending in the United States District Court for the Northern District of California. Additionally, PDS agreed to pay Alliacense $84,000 within 24 hours after Alliacense delivers certain materials to Dominion Harbor Group, LLC, another company providing commercialization services to PDS, and an additional $84,000 out of subsequent recoveries under the Project. PDS and Alliacense have agreed to cause the arbitration between such parties to be dismissed with prejudice and provide mutual releases within 48 hours after PDS's first payment of $84,000 to Alliacense.

The Agreement will terminate six years after the last-to-expire patent in the MMP Portfolio; provided that either party may terminate the agreement in the event of a material breach by the other party that is not cured, if capable of being cured, within 60 days after written notice of the breach.

The foregoing description of the Agreement does not purport to be complete and is qualified in its entirety by reference to the text of the Agreement, a copy of which is attached hereto as Exhibit 10.1.

Share
New Message
Please login to post a reply